Dantrolene for Control of Refractory Shivering in Severe Traumatic Brain Injury: A Case Study

Arisa Kuboyama; Kazuma Sasaki; Takashi Tagami; Yudai Yoshino; Akihiro Watanabe; Kosuke Otake; Junichi Inoue

doi:10.12659/AJCR.944980

17 October 2024 : Case report Japan

Dantrolene for Control of Refractory Shivering in Severe Traumatic Brain Injury: A Case Study

Unusual clinical course, Management of emergency care

Arisa Kuboyama^1ABDEF, Kazuma Sasaki^2ABDEF, Takashi Tagami^12ABDEF*, Yudai Yoshino^12BDE, Akihiro Watanabe^12BDE, Kosuke Otake^12BDE, Junichi Inoue^12BDE

DOI: 10.12659/AJCR.944980

Am J Case Rep 2024; 25:e944980

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Timeline of patient treatment over 32 days after hospitalization. This figure outlines key interventions and monitoring parameters, including targeted temperature management (TTM), intracranial pressure (ICP), and body temperature (BT).

Back to the Article

Dantrolene for Control of Refractory Shivering in Severe Traumatic Brain Injury: A Case Study

Your Privacy